DuPont
Former Searle CEO Richard De Schutter is named DuPont Pharmaceuticals chairman. De Schutter was appointed chief administrative officer of Pharmacia when Monsanto merged with Pharmacia & Upjohn in April, and his retirement from the newly merged company was announced in May. Pharmacia said no plans have been made for a replacement. The position of chairman has been vacant since former DuPont Pharmaceuticals Chairman & CEO Kurt Landgraf left the company in May. Nicholas Teti was named new CEO. Teti and De Schutter report to DuPont Chairman Charles Holiday
More from Archive
More from Pink Sheet
Recognizing that the evidence it receives in applications for health technology assessments will increasingly be informed by artificial intelligence, the CDA-AMC has clarified its expectations for companies that use AI methods in the generation and/or reporting of evidence.
Plozasiran, Arrowhead Pharmaceuticals' treatment for familial chylomicronemia syndrome, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
DIA Korea hears how multiple domestic and global factors are affecting the environment for clinical trials in South Korea, and what actions may be taken to address this.